Gregory M Singer

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial
    Gregory M Singer
    Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8017, USA
    Diabetes Technol Ther 8:636-43. 2006
  2. ncbi Distal embolic protection during renal artery stenting: impact on hypertensive patients with renal dysfunction
    Gregory M Singer
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8017, USA
    J Clin Hypertens (Greenwich) 10:830-6. 2008
  3. ncbi Impact of baseline renal function on outcomes of renal artery stenting in hypertensive patients
    Gregory M Singer
    Department of Internal Medicine, Yale University of School of Medicine, New Haven, CT 06520 8017, USA
    J Clin Hypertens (Greenwich) 11:615-20. 2009
  4. ncbi Secondary hypertension: obesity and the metabolic syndrome
    Gregory M Singer
    Cardiovascular Disease Prevention Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8017, USA
    J Clin Hypertens (Greenwich) 10:567-74. 2008
  5. ncbi Commentary: The ALLHAT Study: implications for the management of resistant hypertension
    Gregory M Singer
    Section of Cardiovascular Medicine, Yale University School of Medicine, 333 Cedar Street, Box 208017, New Haven, CT 06520-8017, USA
    J Clin Hypertens (Greenwich) 7:31-2. 2005

Collaborators

Detail Information

Publications5

  1. ncbi The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial
    Gregory M Singer
    Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8017, USA
    Diabetes Technol Ther 8:636-43. 2006
    ....
  2. ncbi Distal embolic protection during renal artery stenting: impact on hypertensive patients with renal dysfunction
    Gregory M Singer
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8017, USA
    J Clin Hypertens (Greenwich) 10:830-6. 2008
    ..59) and at 12 months (-18 vs -16 mm Hg; P=.89). Renal artery stenting improved eGFR and systolic BP in patients with hypertension and CKD; however, DEP did not enhance these effects...
  3. ncbi Impact of baseline renal function on outcomes of renal artery stenting in hypertensive patients
    Gregory M Singer
    Department of Internal Medicine, Yale University of School of Medicine, New Haven, CT 06520 8017, USA
    J Clin Hypertens (Greenwich) 11:615-20. 2009
    ..10) and 21 mm Hg (P=.02) decrease at 6 and 12 months, respectively. Renal function was stable across all groups. Renal artery stenting reduced BP and produced greatest benefit in patients with baseline impaired renal function...
  4. ncbi Secondary hypertension: obesity and the metabolic syndrome
    Gregory M Singer
    Cardiovascular Disease Prevention Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8017, USA
    J Clin Hypertens (Greenwich) 10:567-74. 2008
    ....
  5. ncbi Commentary: The ALLHAT Study: implications for the management of resistant hypertension
    Gregory M Singer
    Section of Cardiovascular Medicine, Yale University School of Medicine, 333 Cedar Street, Box 208017, New Haven, CT 06520-8017, USA
    J Clin Hypertens (Greenwich) 7:31-2. 2005